The bill amends existing Montana law regarding the emergency use of epinephrine in school settings to include the use of epinephrine nasal spray alongside autoinjectable epinephrine. Specifically, it revises Sections 20-5-420 and 20-5-421 of the Montana Code Annotated (MCA). The amendments define "medication" to include both autoinjectable epinephrine and epinephrine nasal spray, and they allow schools to maintain a stock supply of either form of epinephrine for administration by authorized personnel during anaphylactic emergencies. The bill also outlines the requirements for schools to develop protocols for training staff, maintaining the medication, and ensuring immediate follow-up care after administration.

Additionally, the bill stipulates that schools must inform parents or guardians about the potential use of the epinephrine stock in emergencies and provides liability protections for schools and their employees against claims arising from the administration of epinephrine, except in cases of gross negligence or intentional misconduct. The act is set to take effect immediately upon passage and approval.

Statutes affected:
LC Text: 20-5-420, 20-5-421
SB0211_1(1): 20-5-420, 20-5-421
SB0211_1(10): 20-5-420, 20-5-421
SB0211_1(11): 20-5-420, 20-5-421
SB0211_1(12): 20-5-420, 20-5-421
SB0211_1(2): 20-5-420, 20-5-421
SB0211_1(3): 20-5-420, 20-5-421
SB0211_1(4): 20-5-420, 20-5-421
SB0211_1(5): 20-5-420, 20-5-421
SB0211_1(6): 20-5-420, 20-5-421
SB0211_1(7): 20-5-420, 20-5-421
SB0211_1(8): 20-5-420, 20-5-421
SB0211_1(9): 20-5-420, 20-5-421
SB0211_1: 20-5-420, 20-5-421
SB0211_2: 20-5-420, 20-5-421
SB0211_X(1): 20-5-420, 20-5-421
SB0211_X(2): 20-5-420, 20-5-421
SB0211_X(3): 20-5-420, 20-5-421
SB0211_X(4): 20-5-420, 20-5-421
SB0211_X(5): 20-5-420, 20-5-421
SB0211_X: 20-5-420, 20-5-421